Company / Revenue
Crinetics Pharmaceuticals, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$7.7M
FY2025
5-year range
$1.0M / $7.7M
FY2021-FY2025
Trend
+640.7%
vs FY2024
Sector context
#139 of 155
Health Care
What the data says
Revenue changed +641% YoY in FY2025, a notable deviation from the 9-year average annual change of +142%.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of +26.0%.
Improved from $4M to $8M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- +26.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 155This company $7.7M Sector average $4.5B
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +26.0%, indicating consistent growth.
- In FY2025, revenue increased 640.7% year-over-year.
- Ranks #139 out of 155 companies in the Health Care sector.
- Lowest revenue in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.7M | +640.7% |
| FY2024 | $1.0M | -74.1% |
| FY2023 | $4.0M | -15.3% |
| FY2022 | $4.7M | +339.4% |
| FY2021 | $1.1M | -55.6% |
| FY2020 | $2.4M | +18.7% |
| FY2019 | $2.0M | +247.2% |
| FY2018 | $589.0K | -71.2% |
| FY2017 | $2.0M | +247.2% |
| FY2016 | $589.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026